To The Moon

$Tempus AI(TEM)$ Closing out my entire position for Tempus AI as it has reached a price level that satisfies my risk appetite. Positive earnings and forward guidance met with a dip in price, possibly due to large funds deleveraging. Will be exploring other opportunities in the quantum computing space with caution.

$TSLL 20250516 7.0 PUT$ Got a good price on these TSLL puts one week out. Been winning with this 

$Wilmar Intl(F34.SI)$  Wilmar Could Experience a 'Davis Double Play' This Year – I Hope So. Over the past three years, I have consistently bought the dip in Wilmar's stock. I have occasionally trimmed my position for minor profits, as Wilmar has become overweight in my portfolio. My strategy has been to gradually reduce my holdings during uptrends while realizing some profits along the way. If the stock declines, I plan to buy more and hold for dividend collection. This approach has remained intact for three years. The dividend yield is a crucial anchor point that gives me confidence in holding onto my shares. I believe this strategy will serve me well as I continue to navigate the volatile market.

$Alphabet(GOOGL)$ Investing in Alphabet Inc. (GOOGL) today presents a compelling opportunity for several reasons: ⸻ 🚀 Strong Financial Performance and Valuation • Robust Earnings Growth: Alphabet reported a 12% year-over-year increase in sales and a 230 basis point expansion in operating margins for Q1 2025, indicating solid financial health.  • Attractive Valuation: With a price-to-earnings (P/E) ratio of approximately 16.9, Alphabet’s stock is trading below the S&P 500 average, suggesting it may be undervalued relative to its earnings potential. ⸻ 🤖 Leadership in Artificial Intelligence • AI Integration Across Products: Alphabet is embedding AI technologies like Gemini and AI Overviews into its core services, including Search and Goog

$GDX 20250516 52.0 CALL$ GDX: collect 1.3% premium on this sold call with strike at $52. Contract expires next Fri on 16th May. gold price continue to stay elevated. Still betting that $3500 resistance will be a strong one for now until new catalyst or weakness in the market push it above the level. In the meanwhile, sell new call to capture some premium on the bearish side betting that it will retrace before making the next big move. 

$iShares Core S&P Small-Cap ETF(IJR)$ I opened $iShares Core S&P Small-Cap ETF(IJR)$ ,Take a look at the latest order I posted！ IJR: another weekly DCA into IJR ETF. As it stands, my current average is about 11% in the red so any new purchases as averaging down tv e total cost.  Hope for reversal, yet at the same time understand that it might under perform overmarket in current environment.

$ONEOK Inc(OKE)$ This is a disciplined dollar cost average strategy (DCA) into the OKE. ONEOK, Inc. operates as a midstream service provider of gathering, processing, fractionation, transportation, storage, and marine export services in the United States. It operates in four segments: Natural Gas Gathering and Processing; Natural Gas Liquids; Natural Gas Pipelines; and Refined Products and Crude Their revenue last year was about 21 Billion, with about 10% gross profit, which is rather steady. This is a "REIT" sort of company to me, steady income and good returns. I like this ticker because of the leverage it has in the country. It is very difficult oust them because of how integrated they are. This is a staple for my portfolio. I started buyin

$Novo-Nordisk A/S(NVO)$ Bought more nvo to dca. Novo's financial report: Revenue: $11.87 billion, marking an 18% year-over-year increase, slightly surpassing analyst expectations.  • Earnings per Share (EPS): $0.99, exceeding forecasts. • Operating Profit: 20% increase year-over-year to DKr38.8 billion.  Product Performance: • Ozempic (Type 2 Diabetes): Generated $4.97 billion in sales, outperforming estimates.  • Wegovy (Obesity): Sales reached $2.64 billion, a 90% year-over-year increase but a 13% decline from the previous quarter, falling short of the projected $2.8 billion Nvo is significantly undervalued 

$AMD 20250718 110.0 CALL$ Rolling the covered call now amid post earnings volatility. There is a projected $1.5b annual impact from US export restrictions. Rolling allows me to capture the premium income while maintaining upside exposure during AMD's AI driven growth phase. 

$AMZN 20250523 200.0 CALL$ AMZN: collect 0.75% premium from this covered call with strike at $200.  Contract expires in 3 weeks on 23rd May.  Stock touch its small resistence level of $192 and might retrace or breakout depending on general market.  Earnings already out so that took away an element of uncertainty.  Tariffs will certainly hit its product business but the web services and entertainment should survive mostly intact.  Selling new short duration calls to capture come premium but also aware the timing might not be perfect.  $200 should provide additional resistance to slow down or to break higher.

$Alphabet(GOOG)$ GOOG: bought in some additional shares to average down and increase my share holding on GOOG.  The sell down on news that AAPL might consider adding AI services into their phones that might impede the success of Google search and other services which until recently was a captured market due to AAPL and GOOG unique tie up collaboration whigh GOOG pays AAPL a significant sum to stay a a default search app. 

$CLSK 20250919 7.0 PUT$ Closing part of my put, taking partial profit. Will resell when CLSK falls again

$UnitedHealth(UNH)$ All time high: $630 Current price: $380 (-40% from all time high)  PE at 16 Hope stock price can drop more to buy more share at cheaper price. 

$Pfizer(PFE)$ I bought PFE because I believe the concerns over pharmaceutical tariffs are being overstated and in addition, PFE offers a strong dividend yield.

$NIO 20250509 4.0 PUT$ Got assigned to buy 5,000 shares but it's ok. Sold $6 calls in response

$TSLL 20250509 7.0 PUT$ Good money here. Managing selling puts well enough to earn a few 100 USD per week. The goal is to have a strategy good enough for 3-4k usd per month as a form of semi passive income.

$COIN 20250509 220.0 CALL$ Safely sold this 2 x set of covered calls which was expiring in a few days. Will look to sell more CCs on a weekly/ bi weekly basis if IV increases.

$META 20250509 442.5 PUT$ 3rd option expiry meta strong performance due to strong earnings 

$PLTR 20250509 68.0 PUT$ 13th option expiry On palantir great results Palantir Technologies Inc. recently reported impressive financial results with Guidance*: For 2025, Palantir expects revenue growth of 31% year-over-year, with U.S. commercial revenue exceeding $1.079 billion, representing a growth rate of at least 54%